All entries for: Adicet Bio, Inc.

March 12, 2026

Adicet Bio, Inc.

Neutral Outlook

Boston, MA
51-200 employees

Although the effects of the IRA on our business and the healthcare industry in general is not yet known, we are taking into consideration the potential impact of the IRA on our development and commercialization activities.

Disease Area: Hematology, Immune Diseases, Oncology
Drug Type: Biologic
Scroll to Top